Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms

Cryoballoon ablation (CBA) as a first-line rhythm control strategy is superior to antiarrhythmic drugs (AADs) for preventing atrial fibrillation (AF) recurrence; the impact of first-line CBA on quality of life (QoL) and symptoms has not been well characterized. Patients aged 18 to 75 with symptomati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2021-12, Vol.242, p.103-114
Hauptverfasser:	Pavlovic, Nikola, Chierchia, Gian-Battista, Velagic, Vedran, Hermida, Jean Sylvain, Healey, Stewart, Arena, Giuseppe, Badenco, Nicolas, Meyer, Christian, Chen, Jian, Iacopino, Saverio, Anselme, Frédéric, Dekker, Lukas, Scazzuso, Fernando, Packer, Douglas L, de Asmundis, Carlo, Pitschner, Heinz-Friedrich, Piazza, Fabio Di, Kaplon, Rachelle E, Kuniss, Malte
Format:	Artikel
Sprache:	eng
Schlagworte:	Ablation Adolescent Adult Aged Anti-Arrhythmia Agents - therapeutic use Arrhythmia Atrial Fibrillation - drug therapy Atrial Fibrillation - surgery Blanking Cardiac arrhythmia Catheter Ablation Catheters Chemotherapy Cryosurgery Drug therapy Fibrillation Human health and pathology Humans Life Sciences Mental health Middle Aged Patients Polar environments Quality of Life Questionnaires Rhythm Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!